TNF Hampers Intestinal Tissue Repair in Colitis by Restricting IL-22 Bioavailability
7 Articles
7 Articles
TNF hampers intestinal tissue repair in colitis by restricting IL-22 bioavailability
Successful treatment of chronic inflammatory diseases integrates both the cessation of inflammation and the induction of adequate tissue repair processes. Strikingly, targeting a single proinflammatory cytokine, tumor necrosis factor (TNF), induces both processes in a relevant cohort of inflammatory bowel disease (IBD) patients. However, the molecular mechanisms underlying intestinal repair following TNF blockade during IBD remain elusive. Using…
Spatial mapping reveals network of cells and genes involved in Crohn's disease complication
Up to half of patients with Crohn's disease, an inflammatory bowel disease, develop a complication called fibrosis, where the gut becomes scarred and obstructed, causing pain and bloating. Currently, the only treatment option for these gut "strictures" is surgery.
Study: Crohn’s Disease Investigational Treatment Shows Potential for Achieving Remission
Cedars-Sinai investigators have developed an investigational therapy that brought a significant number of patients with moderate to severe Crohn's disease into remission, according to a new study published in The Lancet Gastroenterology & Hepatology.
Fecal Transplant for Ulcerative Colitis (UC): Does It Work?
If you have ulcerative colitis (UC), you may wish you could swap out your entire digestive system. There's a potential treatment that may come close: someone else's fecal matter. Often called fecal microbiota transplants (FMT), this procedure involves specially prepared fecal samples from a healthy donor — one without UC or other digestive conditions — which is introduced into the large intestine (colon) of someone with an inflammatory disease l…
Milan, 25 Jun. (askanews) - To bring out the experience of patients with Crohn's Disease to raise awareness of this disease. These are the objectives of the campaign "Crohnostorie. Stories of those who face Crohn's disease every day" designed by AbbVie in collaboration with Amici Italia Ets and Ig-Ibd. The campaign, launched in an event at the Cairoli Space in Milan, focuses on an installation of great communicative impact.
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium